HK1100226A1 - Compositions comprising fetal liver cells and methods useful for hcv infection - Google Patents

Compositions comprising fetal liver cells and methods useful for hcv infection

Info

Publication number
HK1100226A1
HK1100226A1 HK07108310.9A HK07108310A HK1100226A1 HK 1100226 A1 HK1100226 A1 HK 1100226A1 HK 07108310 A HK07108310 A HK 07108310A HK 1100226 A1 HK1100226 A1 HK 1100226A1
Authority
HK
Hong Kong
Prior art keywords
compositions
liver cells
hcv infection
methods useful
fetal liver
Prior art date
Application number
HK07108310.9A
Other languages
English (en)
Inventor
Randal Byrn
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of HK1100226A1 publication Critical patent/HK1100226A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/18—Liver cell growth factor (LCGF, Gly-His-Lys)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/335—Glucagon; Glucagon-like peptide [GLP]; Exendin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK07108310.9A 2003-12-01 2007-07-30 Compositions comprising fetal liver cells and methods useful for hcv infection HK1100226A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52641103P 2003-12-01 2003-12-01
PCT/US2004/039964 WO2005054450A1 (fr) 2003-12-01 2004-12-01 Compositions renfermant des cellules hepatiques foetales, et procedes utiles pour le traitement de l'infection par le vhc

Publications (1)

Publication Number Publication Date
HK1100226A1 true HK1100226A1 (en) 2007-09-14

Family

ID=34652451

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07108310.9A HK1100226A1 (en) 2003-12-01 2007-07-30 Compositions comprising fetal liver cells and methods useful for hcv infection

Country Status (8)

Country Link
US (1) US20050287514A1 (fr)
EP (1) EP1689857A1 (fr)
JP (1) JP2007516706A (fr)
CN (1) CN1910275B (fr)
AU (1) AU2004295702A1 (fr)
CA (1) CA2547787A1 (fr)
HK (1) HK1100226A1 (fr)
WO (1) WO2005054450A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA66767C2 (uk) 1996-10-18 2004-06-15 Вертекс Фармасьютикалс Інкорпорейтед Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
TWI359147B (en) 2003-09-05 2012-03-01 Vertex Pharma Inhibitors of serine proteases, particularly hcv n
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
WO2007046962A2 (fr) * 2005-09-02 2007-04-26 The University Of Maryland, Baltimore Lignees cellulaires hebergeant le virus de l'hepatite et procedes d'utilisation de celles-ci
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
US8039475B2 (en) 2006-02-27 2011-10-18 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
WO2007109080A2 (fr) 2006-03-16 2007-09-27 Vertex Pharmaceuticals Incorporated Inhibiteurs de protéase de l'hépatite c deutérés
CN101903392A (zh) 2007-02-27 2010-12-01 弗特克斯药品有限公司 丝氨酸蛋白酶的抑制剂
JP2010519330A (ja) 2007-02-27 2010-06-03 バーテックス ファーマシューティカルズ インコーポレイテッド 共結晶体およびそれを含む医薬組成物
CN101835774B (zh) 2007-08-30 2014-09-17 弗特克斯药品有限公司 共晶体和包含该共晶体的药物组合物
JP2009254292A (ja) * 2008-04-17 2009-11-05 Tosoh Corp 細胞融合装置及び細胞融合方法
CN101463345B (zh) * 2008-12-26 2012-03-21 青岛易邦生物工程有限公司 一种病毒繁殖促进剂及其应用
JP2015092852A (ja) * 2013-11-12 2015-05-18 倉敷紡績株式会社 生体組織分散用組成物
EP3595686A4 (fr) * 2017-02-01 2020-12-02 PhoenixSongs Biologicals, Inc. Compositions et procédés comprenant la co-culture d'hépatocytes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529920A (en) * 1988-12-14 1996-06-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human liver epithelial cell line and culture media therefor
WO1992003046A1 (fr) * 1990-08-28 1992-03-05 Somatix Therapy Corporation Procede ameliore de cryoconservation de cellules
US5849686A (en) * 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5723282A (en) * 1991-07-08 1998-03-03 The American National Red Cross Method of preparing organs for vitrification
US6069005A (en) * 1991-08-07 2000-05-30 Albert Einstein College Of Medicine Of Yeshwa University Hapatoblasts and method of isolating same
JPH07501206A (ja) * 1991-08-07 1995-02-09 イェシバ・ユニバーシティ 前駆肝細胞の増殖
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5795711A (en) * 1996-04-04 1998-08-18 Circe Biomedical, Inc. Cryopreserved hepatocytes and high viability and metabolic activity
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
EP0972828A1 (fr) * 1998-06-24 2000-01-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procés pour la réplication in vitro du HCV
US6787356B1 (en) * 1998-07-24 2004-09-07 The United States Of America As Represented By The Department Of Health And Human Services Cell expansion system for use in neural transplantation
KR19990014353A (ko) * 1998-10-17 1999-02-25 윤태욱 췌도의 대량 배양증식방법
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
HUP0203781A2 (hu) * 2000-01-19 2003-03-28 University Of North Carolina At Chapel Hill Májszövet-forrás
US20020045156A1 (en) * 2000-05-16 2002-04-18 Mehmet Toner Microinjection of cryoprotectants for preservation of cells
US6762053B2 (en) * 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
US6521402B1 (en) * 2000-06-14 2003-02-18 The Texas A&M University System Cryopreservation of tissues for use in nuclear transfer
US6656170B2 (en) * 2000-12-08 2003-12-02 Sca Hygiene Products Ab Absorbent article with improved leakage safety
CA2441688C (fr) * 2001-03-27 2014-01-21 Vertex Pharmaceuticals Incorporated Compositions et methodes de traitement de l'infection par le vhc
US7150991B2 (en) * 2002-04-01 2006-12-19 Virginia Tech Intellectual Properties, Inc. Method to preserve cells
WO2004003172A2 (fr) * 2002-07-01 2004-01-08 Pharmacia Corporation Gene esm-1 exprime differentiellement dans l'angiogenese, antagonistes de dernier et methodes d'utilisation correspondantes

Also Published As

Publication number Publication date
CN1910275A (zh) 2007-02-07
CN1910275B (zh) 2011-04-27
AU2004295702A1 (en) 2005-06-16
CA2547787A1 (fr) 2005-06-16
JP2007516706A (ja) 2007-06-28
US20050287514A1 (en) 2005-12-29
EP1689857A1 (fr) 2006-08-16
WO2005054450A1 (fr) 2005-06-16

Similar Documents

Publication Publication Date Title
HK1100226A1 (en) Compositions comprising fetal liver cells and methods useful for hcv infection
HK1076227A1 (en) Compositions and methods for liver growth and liver protection
GB0411940D0 (en) Methods and compositions
EP1701725A4 (fr) Methodes et compositions
AU2003257013A1 (en) Methods and compositions for amplification of dna
ZA200509760B (en) Composition for maintaining organ and cell viability
EP1644516A4 (fr) Methodes et compositions de detection du virus du sras et d'autres agents infectieux
EP1692131A4 (fr) Methodes et compositions de ralentissement du vieillissement
AU2003248862A1 (en) Compositions and fabrication methods for hardmetals
AU2002318944A1 (en) Methods and compositions relating to plasmacytoid dendritic cells
HK1180218A1 (en) Methods and compositions involving mda-7 mda-7
EP1633718A4 (fr) Compositions et procedes d'inhibition du facteur de croissance transformant beta (tgf-$g(b))
AU2003256334A8 (en) Inhibitors of hcv upjohn company
PL1670440T3 (pl) Preparaty HRT
EP1680535A4 (fr) Procedes et compositions pour galvanoplastie
AU2003256805A8 (en) Compounds compositions and methods
EP1482788A4 (fr) Compositions comprenant des milieux pour des cellules reproductrices et procede d'utilisation de telles compositions
EP1487965A4 (fr) Compositions minicellulaires et methodes associees
IL173630A0 (en) Pharmaceutical compositions and kits containing ribavirin and interferon
AU2003270310A8 (en) Compositions and methods for synthesizing nucleic acids
AU2003257109A8 (en) Compositions and methods for molecular biology
AU2003275268A8 (en) Hemostatic compositions and methods
EP1572991A4 (fr) Compositions et methodes d'hydroxylation d'epothilones
AU2003229474A8 (en) Methods and compositions for detecting sars virus
IL174870A0 (en) Indole antiviral compositions and methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141201